KPCM
SNY icon

Kings Point Capital Management’s Sanofi SNY Stock Holding History

Kings Point Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$10K Hold
200
– – ﹤0.01% 570
2021
Q4 		$10K Buy
+200
New +$9.89K ﹤0.01% 634

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Kings Point Capital Management's SNY Position: Q1 2022 in Review

Kings Point Capital Management held its Sanofi (SNY) position steady in Q1 2022 at 200 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Kings Point Capital Management first reported a position in SNY in Q4 2021 and has held it in 2 quarters since. 624 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

  • Kings Point Capital Management held 200 shares of Sanofi worth $10K as of Q1 2022.
  • Kings Point Capital Management left its Sanofi share count unchanged in Q1 2022.
  • Sanofi made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #570 holding.
  • Kings Point Capital Management first reported a position in Sanofi in Q4 2021 and has held it in 2 quarters since.
  • 624 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.